2-cyclopropyl-1H-1,3-benzodiazole-5-carboxylic acid hydrochloride, 95.0%, 1g

3-(4-bromo-1H-pyrazol-1-yl)propan-1-ol, 95.0%, 1g

4-Amino-2-(ethylthio)-5-(hydroxymethyl)pyrimidine, 98.0%, 1g

ROTIPHORESE®10x TBE Buffer, 2.5 l, glass, 1 x 2.5 l

3-Fluorobenzylamine>98.0%(GC)(T)5g

[(3-phenyl-1H-pyrazol-4-yl)methyl]amine dihydrochloride, 95.0%, 250mg

(R)-2-AMINO-3-((TERT-BUTOXYCARBONYL)AMINO)-3-METHYLBUTANOIC ACID, 95.0%, 250mg

1,3-Di-tert-butylimidazolium Hydrogencarbonate (contains varying amounts of 1,3-Di-tert-butylimidazolium-2-carboxylate)>98.0%(HPLC)1g

tert-Butyl 2-(propan-2-ylidene)hydrazinecarboxylate, 95.0%, 25g

GC capillary column ROTI®Cap-624, 30 m, 0.32 mm, 1.80 µm, 1 Piece(s)

2,4-Dichloro-5-fluoro-3-nitrobenzoic acid, 97.0%, 5g

4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)thiomorpholine 1,1-dioxide, 98%, 5g

2,6-DIHYDROXYTEREPHTHALIC ACID, 95%, 25g